Press release
Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market
Liposomal Drug Delivery Devices Market
Projected Market Size Expansion for Liposomal Drug Delivery Devices
The liposomal drug delivery devices market is anticipated to experience rapid growth over the coming years. By 2030, the market size is forecasted to reach $9.49 billion, growing at a compound annual growth rate (CAGR) of 12.1%. Several factors are contributing to this expansion, including heightened demand for targeted cancer therapies, increased adoption of personalized medicine, broader use of advanced drug delivery platforms, and rising investments in biologics and vaccines. There is also a growing emphasis on reducing drug toxicity, which further propels market growth. Key trends expected to shape this market through 2030 include the rising use of targeted drug delivery systems, the expanding application of pegylated liposomal formulations, increased use in oncology treatments, growth in liposomal vaccines and antifungal therapies, and a stronger focus on controlled drug release technologies.
Download a free sample of the liposomal drug delivery devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3349&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Top Companies Leading the Liposomal Drug Delivery Devices Market
The market features several prominent players who hold significant influence in shaping its trajectory. Leading companies include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Gilead Sciences Inc., Ipsen SA, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, and Taiwan Liposome Company.
Collaborative Developments in the Liposomal Drug Delivery Sector
In October 2024, Liquidia Corporation, a US-based biopharmaceutical company specializing in rare cardiopulmonary diseases, expanded its partnership with Pharmosa Biopharm to advance the development of L606. This collaboration aims to enhance Liquidia's liposomal drug delivery capabilities by integrating Pharmosa's proprietary liposomal formulation and inhalation device technologies. Together, they are co-developing L606, a sustained-release inhaled treprostinil therapy. Pharmosa Biopharm, headquartered in Taiwan, focuses on pioneering drugs through advanced liposomal delivery systems and inhalation platforms, bolstering the innovation pipeline in this area.
View the full liposomal drug delivery devices market report:
https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Innovative Product Introductions Shaping the Liposomal Drug Delivery Market
Major market participants are actively launching new products to maintain a competitive edge. A notable example occurred in August 2024, when Lupin Ltd., an Indian pharmaceutical company, introduced Doxorubicin Hydrochloride Liposome Injection in dosages of 20 mg/10 mL and 50 mg/25 mL. This product, focused on oncology treatment, held estimated annual sales of around USD 40.9 million in the US market as of June 2024. Lupin's entry into this space highlights their commitment to advancing patient health by offering effective treatment options amidst intense competition within the pharmaceutical landscape.
Market Segmentation and Forecasts for the Global Liposomal Drug Delivery Devices Industry
The report categorizes the liposomal drug delivery devices market into distinct segments for clearer analysis:
1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users
Further subsegment details include:
- Liposomal Doxorubicin: Conventional and PEGylated formulations
- Liposomal Paclitaxel: Conventional and PEGylated formulations
- Liposomal Amphotericin B: Conventional and PEGylated formulations
- Other Types: Liposomal Irinotecan, Liposomal Vincristine, Liposomal Cytarabine
These segments provide a comprehensive overview of the diverse product types, clinical applications, and user groups that define and drive the liposomal drug delivery devices market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market here
News-ID: 4450822 • Views: …
More Releases from The Business Research Company
Analysis of Key Market Segments Influencing the Magnetic Resonance Imaging Syste …
The magnetic resonance imaging (MRI) systems devices and equipment market is set for consistent growth over the coming years, driven by technological advancements and evolving healthcare demands. As MRI technology continues to improve and integrate cutting-edge features, this market is poised to expand steadily up to 2030. Below is a detailed overview of the market size, key players, emerging trends, and segment-wise forecasts shaping this evolving sector.
Magnetic Resonance Imaging Systems…
Future Perspectives: Key Trends Shaping the Intramedullary Nails Market up to 20 …
The intramedullary nails market is set for impressive growth in the coming years, driven by technological advancements and demographic changes. As innovations continue improving treatment outcomes, this sector is gaining momentum worldwide. Let's explore the market size projections, key players, emerging trends, and segmentation shaping the future of intramedullary nails.
Expected Market Size Growth of the Intramedullary Nails Market Through 2030
The market for intramedullary nails is anticipated to reach $1.32 billion…
Outlook on the Low Temperature Plasma Sterilizer Market: Major Segments, Strateg …
The low temperature plasma sterilizer market is gaining significant attention due to its advanced sterilization capabilities for sensitive medical instruments. As healthcare settings increasingly prioritize patient safety and efficient infection control, this market is well-positioned for strong growth. Let's explore the market's projected value, leading companies, current trends, and detailed segment insights to understand its future trajectory.
Anticipated Market Value of the Low Temperature Plasma Sterilizer Market by 2030
The low temperature…
In-Depth Examination of Segments, Industry Trends, and Key Players in the Intrac …
The intracranial stents market is on the verge of significant expansion, driven by advances in neurovascular technology and a growing emphasis on early stroke treatment. As innovations continue to emerge, this sector is set to experience substantial growth, offering promising opportunities for both healthcare providers and medical device manufacturers.
Intracranial Stents Market Size and Projected Growth by 2030
The market for intracranial stents is expected to expand rapidly, reaching a value of…
More Releases for Liposomal
What is Liposomal Vitamin C? | ONS & FSMP Guide
What Does "Liposomal" Mean? Understanding Liposomal Vitamin C.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/wechat_2025-08-06_015004_689.png
Modern supplements promise more than ever, yet many nutrients break down before your body can use them. SINOFN Health harnesses liposomal technology to protect vitamins like vitamin C in tiny phospholipid spheres-so they glide through digestion intact and deliver maximum potency.
How Liposomes Work
*
They encapsulate water-soluble nutrients at their core or embed fat-soluble compounds in their lipid layers.
*
When liposomes reach the…
Rising Prevalence Of Cancer Fuels Growth In Liposomal Doxorubicin Market: A Sign …
The Liposomal Doxorubicin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Liposomal Doxorubicin Market Size and Projected Growth Rate?
The liposomal doxorubicin market has also shown strong growth in recent years. It is expected to grow from $1.23 billion in 2024 to $1.32…
Key Trend Reshaping the Liposomal Drug Delivery Devices Market in 2025: Strategi …
What industry-specific factors are fueling the growth of the liposomal drug delivery devices market?
The global increase in cancer cases is expected to bolster the liposomal drug delivery devices market in the future. These delivery systems offer targeted treatments for cancer through radiation therapy, chemotherapy, and surgical resection. For example, data from UK-based charity, Macmillan Cancer Support, in June 2022, revealed a cancer prevalence of 3 million in 2022, which is…
Liposomal Supplements Market Research Report 2023
Liposomal Supplements Market
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-31J7848/Global_and_China_Liposomal_Supplements_Market_Insights_Forecast_to_2027
North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029,…
Liposomal Supplements Market Research Report 2023 - valuates reports
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of %…
Liposomal Doxorubicin Market - Powerful Delivery, Enhanced Outcomes: Empowering …
Newark, New Castle, USA - new report, titled Liposomal Doxorubicin Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liposomal Doxorubicin market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liposomal Doxorubicin market. The report offers an overview of the market, which…
